Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. T...

Full description

Saved in:
Bibliographic Details
Published in:Hepatology (Baltimore, Md.) Vol. 44; no. 4; pp. 874 - 880
Main Authors: Merriman, Raphael B., Ferrell, Linda D., Patti, Marco G., Weston, Shiobhan R., Pabst, Mark S., Aouizerat, Bradley E., Bass, Nathan M.
Format: Journal Article
Language:English
Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01-10-2006
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. This prospective study aimed to correlate precise histological findings in paired biopsies—right and left lobe—in the diagnosis of NAFLD in morbidly obese subjects undergoing bariatric surgery employing both Brunt and Matteoni classifications and the NAFLD Activity Score (NAS). We also aimed to determine whether the composite histopathological findings of the two biopsies would improve diagnostic accuracy. Consecutive subjects had an intraoperative biopsy from both right and left lobes, evaluated and scored in a blinded manner. Intraobserver agreement was also assessed. Kappa coefficients of agreement were calculated. Forty‐one subjects had acceptable biopsies. Agreement for steatosis was excellent and moderate for fibrosis. Concordance was only fair for most features of necroinflammation. Intraobserver agreement was only moderate for lobular inflammation. Excellent agreement was seen for the diagnosis of NASH using Brunt criteria and good agreement when using Matteoni and NAS scoring systems. Composite biopsy data particularly improved identification of hepatocyte ballooning. The diagnostic accuracy also improved substantially when composite features were compared with single‐sided biopsy features, especially for the Matteoni and NAS scoring systems. In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease. (HEPATOLOGY 2006;44:874–880.)
AbstractList In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. This prospective study aimed to correlate precise histological findings in paired biopsies--right and left lobe--in the diagnosis of NAFLD in morbidly obese subjects undergoing bariatric surgery employing both Brunt and Matteoni classifications and the NAFLD Activity Score (NAS). We also aimed to determine whether the composite histopathological findings of the two biopsies would improve diagnostic accuracy. Consecutive subjects had an intraoperative biopsy from both right and left lobes, evaluated and scored in a blinded manner. Intraobserver agreement was also assessed. Kappa coefficients of agreement were calculated. Forty-one subjects had acceptable biopsies. Agreement for steatosis was excellent and moderate for fibrosis. Concordance was only fair for most features of necroinflammation. Intraobserver agreement was only moderate for lobular inflammation. Excellent agreement was seen for the diagnosis of NASH using Brunt criteria and good agreement when using Matteoni and NAS scoring systems. Composite biopsy data particularly improved identification of hepatocyte ballooning. The diagnostic accuracy also improved substantially when composite features were compared with single-sided biopsy features, especially for the Matteoni and NAS scoring systems. In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease.
In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. This prospective study aimed to correlate precise histological findings in paired biopsies—right and left lobe—in the diagnosis of NAFLD in morbidly obese subjects undergoing bariatric surgery employing both Brunt and Matteoni classifications and the NAFLD Activity Score (NAS). We also aimed to determine whether the composite histopathological findings of the two biopsies would improve diagnostic accuracy. Consecutive subjects had an intraoperative biopsy from both right and left lobes, evaluated and scored in a blinded manner. Intraobserver agreement was also assessed. Kappa coefficients of agreement were calculated. Forty‐one subjects had acceptable biopsies. Agreement for steatosis was excellent and moderate for fibrosis. Concordance was only fair for most features of necroinflammation. Intraobserver agreement was only moderate for lobular inflammation. Excellent agreement was seen for the diagnosis of NASH using Brunt criteria and good agreement when using Matteoni and NAS scoring systems. Composite biopsy data particularly improved identification of hepatocyte ballooning. The diagnostic accuracy also improved substantially when composite features were compared with single‐sided biopsy features, especially for the Matteoni and NAS scoring systems. In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease. (HEPATOLOGY 2006;44:874–880.)
Author Patti, Marco G.
Merriman, Raphael B.
Weston, Shiobhan R.
Pabst, Mark S.
Aouizerat, Bradley E.
Ferrell, Linda D.
Bass, Nathan M.
Author_xml – sequence: 1
  givenname: Raphael B.
  surname: Merriman
  fullname: Merriman, Raphael B.
  email: raphael.merriman@ucsf.edu
– sequence: 2
  givenname: Linda D.
  surname: Ferrell
  fullname: Ferrell, Linda D.
– sequence: 3
  givenname: Marco G.
  surname: Patti
  fullname: Patti, Marco G.
– sequence: 4
  givenname: Shiobhan R.
  surname: Weston
  fullname: Weston, Shiobhan R.
– sequence: 5
  givenname: Mark S.
  surname: Pabst
  fullname: Pabst, Mark S.
– sequence: 6
  givenname: Bradley E.
  surname: Aouizerat
  fullname: Aouizerat, Bradley E.
– sequence: 7
  givenname: Nathan M.
  surname: Bass
  fullname: Bass, Nathan M.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18178906$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17006934$$D View this record in MEDLINE/PubMed
BookMark eNp10EFv1DAQBWALFdFt4cAfQL6AxCHtOInX9hGtCkWqBAc4R_ZkojXyxsGTpdp_T8pG6omTL5_fG70rcTHmkYR4q-BGAdS3e5puatW02xdio3RtqqbRcCE2UBuonGrcpbhi_gUArq3tK3GpDMDWNe1G5F0uhZKfYx5lHuTkY6FepviHigwxTxyJZRzlIZcQ-3SSORDT4uZI48zyMc57yUeeCOfl43KZT5j3OUWUg5_n05rVRybP9Fq8HHxierO-1-Ln57sfu_vq4duXr7tPDxU2utlWAcCg6hXYgK1xdQiq1wgQDAXSqCySNy6gHYw3pC1aRO0wELZU675vrsWHc-5U8u8j8dwdIiOl5EfKR-621ilja73Aj2eIJTMXGrqpxIMvp05B97Rut6zb_Vt3se_W0GM4UP8s1zkX8H4FntGnofgRIz87u3Q6eAq6PbvHmOj0_8bu_u77ufovqB-V4Q
CODEN HPTLD9
CitedBy_id crossref_primary_10_1016_S0221_0363_09_73268_8
crossref_primary_10_1148_radiol_11110156
crossref_primary_10_1016_j_jhep_2017_11_012
crossref_primary_10_1002_hep_27173
crossref_primary_10_1111_j_1572_0241_2007_01774_x
crossref_primary_10_1016_S1590_8658_11_60589_6
crossref_primary_10_1097_01_rli_0000258058_44876_a5
crossref_primary_10_1111_j_1440_1746_2010_06437_x
crossref_primary_10_1371_journal_pone_0238717
crossref_primary_10_1007_s15034_014_0624_4
crossref_primary_10_1259_bjr_20120653
crossref_primary_10_1053_j_gastro_2016_10_026
crossref_primary_10_1111_j_1872_034X_2012_01027_x
crossref_primary_10_14218_JCTH_2021_00024
crossref_primary_10_1016_j_cgh_2021_05_059
crossref_primary_10_1097_MOG_0b013e3280b0841f
crossref_primary_10_3350_cmh_2013_19_2_116
crossref_primary_10_3748_wjg_v24_i44_5005
crossref_primary_10_1371_journal_pone_0199166
crossref_primary_10_1016_S2468_1253_20_30357_5
crossref_primary_10_4254_wjh_v7_i3_575
crossref_primary_10_3748_wjg_v20_i29_10108
crossref_primary_10_1002_lt_25733
crossref_primary_10_1016_j_jceh_2021_08_002
crossref_primary_10_1007_s11695_020_04991_6
crossref_primary_10_1111_j_1440_1746_2011_06760_x
crossref_primary_10_2957_kanzo_50_741
crossref_primary_10_1002_hep_22603
crossref_primary_10_1007_s12072_019_09945_4
crossref_primary_10_1111_j_1751_2980_2010_00471_x
crossref_primary_10_1016_S1665_2681_19_30923_8
crossref_primary_10_1016_j_clinre_2011_10_011
crossref_primary_10_1007_s00535_021_01796_x
crossref_primary_10_1111_j_1478_3231_2011_02451_x
crossref_primary_10_1053_j_gastro_2020_06_006
crossref_primary_10_1007_s11892_008_0006_1
crossref_primary_10_1002_hep_21768
crossref_primary_10_1111_j_1872_034X_2011_00923_x
crossref_primary_10_1007_s11695_007_9398_2
crossref_primary_10_1002_hep_22185
crossref_primary_10_1038_s41598_023_33964_9
crossref_primary_10_1002_lt_23786
crossref_primary_10_1016_j_gcb_2009_02_028
crossref_primary_10_1186_s12902_022_00980_1
crossref_primary_10_1371_journal_pone_0271572
crossref_primary_10_12659_MSM_883601
crossref_primary_10_1111_j_1872_034X_2008_00407_x
crossref_primary_10_1148_radiol_2017160588
crossref_primary_10_1016_j_jhep_2010_08_023
crossref_primary_10_3238_arztebl_2014_0447
crossref_primary_10_1007_s00535_012_0581_4
crossref_primary_10_1016_j_ultrasmedbio_2012_08_010
crossref_primary_10_1111_j_1365_2036_2007_03425_x
crossref_primary_10_2147_HMER_S278076
crossref_primary_10_1007_s12664_023_01339_7
crossref_primary_10_1016_j_humpath_2013_11_011
crossref_primary_10_1111_hpb_12348
crossref_primary_10_1039_C5AN01080B
crossref_primary_10_1016_j_tips_2020_12_001
crossref_primary_10_1097_MEG_0b013e32832ca0cb
crossref_primary_10_1016_j_cgh_2018_08_055
crossref_primary_10_1038_oby_2009_154
crossref_primary_10_1111_j_1365_2036_2008_03752_x
crossref_primary_10_1002_hep_23050
crossref_primary_10_1007_s00330_019_06072_4
crossref_primary_10_1097_MEG_0000000000000919
crossref_primary_10_3892_etm_2024_12573
crossref_primary_10_1007_s00261_016_0699_6
crossref_primary_10_1002_hep_23727
crossref_primary_10_1186_1471_230X_12_2
crossref_primary_10_1111_j_1753_0407_2012_00204_x
crossref_primary_10_1111_j_1365_2036_2011_04695_x
crossref_primary_10_1080_00365520802555991
crossref_primary_10_1242_dmm_014472
crossref_primary_10_1007_s00261_022_03647_6
crossref_primary_10_1111_liv_13549
crossref_primary_10_3109_10408363_2011_596521
crossref_primary_10_1016_j_cld_2012_05_006
crossref_primary_10_1016_S1262_3636_08_74598_1
crossref_primary_10_1111_j_1872_034X_2010_00704_x
crossref_primary_10_1016_S0973_6883_12_60103_0
crossref_primary_10_4254_wjh_v6_i5_306
crossref_primary_10_1016_j_molmet_2021_101167
crossref_primary_10_1016_j_clinre_2011_08_001
crossref_primary_10_1111_jgh_14654
crossref_primary_10_1080_17474124_2018_1415756
crossref_primary_10_1016_j_cld_2017_08_004
crossref_primary_10_1111_j_1478_3231_2010_02264_x
crossref_primary_10_1007_s11695_014_1235_9
crossref_primary_10_1016_j_jhep_2008_07_035
crossref_primary_10_1016_j_ultrasmedbio_2013_02_013
crossref_primary_10_1586_egh_10_56
crossref_primary_10_1093_gastro_got006
crossref_primary_10_1016_j_ultrasmedbio_2019_03_021
crossref_primary_10_1016_j_jhep_2011_06_010
crossref_primary_10_1007_s00330_009_1330_9
crossref_primary_10_1007_s12072_022_10303_0
crossref_primary_10_1053_j_gastro_2008_08_050
crossref_primary_10_1111_j_1872_034X_2012_00976_x
crossref_primary_10_1002_hep_28776
crossref_primary_10_17941_agd_799535
crossref_primary_10_1007_s00535_010_0305_6
crossref_primary_10_3350_kjhep_2009_15_2_122
crossref_primary_10_1016_j_vascn_2019_106651
crossref_primary_10_1111_j_1440_1746_2010_06612_x
crossref_primary_10_3390_ijms21114189
crossref_primary_10_1016_j_ejrad_2018_08_008
crossref_primary_10_1016_j_humpath_2015_01_019
crossref_primary_10_3109_00365521_2011_634024
crossref_primary_10_1586_egh_11_97
crossref_primary_10_1016_j_mri_2011_07_028
crossref_primary_10_1097_MOL_0b013e32834c7cfc
crossref_primary_10_1148_radiol_13121193
crossref_primary_10_34172_mejdd_2023_316
crossref_primary_10_1016_S0929_6646_09_60026_7
crossref_primary_10_1517_17530059_2012_691878
crossref_primary_10_1007_s00261_018_1745_3
crossref_primary_10_3390_jcm11154581
crossref_primary_10_1002_hep_30974
crossref_primary_10_1016_j_cld_2015_10_007
crossref_primary_10_2214_AJR_10_5215
crossref_primary_10_1002_jmri_25843
crossref_primary_10_1111_nyas_12016
crossref_primary_10_2214_AJR_11_6729
crossref_primary_10_1055_a_1880_2283
crossref_primary_10_4103_NJGH_NJGH_9_20
crossref_primary_10_1111_hepr_12432
crossref_primary_10_1111_j_1872_034X_2012_01106_x
crossref_primary_10_1002_hep_23784
crossref_primary_10_1002_lt_23832
crossref_primary_10_1002_hep_29639
crossref_primary_10_2217_bmm_2017_0361
crossref_primary_10_1016_j_annpat_2010_10_002
crossref_primary_10_1002_hep4_1119
crossref_primary_10_4254_wjh_v2_i10_374
crossref_primary_10_1007_s00535_012_0704_y
crossref_primary_10_1016_j_ultrasmedbio_2018_03_011
crossref_primary_10_1053_j_gastro_2016_03_005
crossref_primary_10_1007_s12072_022_10373_0
crossref_primary_10_3389_fphys_2022_1046497
crossref_primary_10_1016_j_jhep_2016_06_005
crossref_primary_10_1097_MEG_0000000000000671
crossref_primary_10_1111_1751_2980_12088
crossref_primary_10_1002_jmri_21837
crossref_primary_10_1111_apt_17707
crossref_primary_10_1111_j_1365_2036_2011_04740_x
crossref_primary_10_1002_hep_28317
crossref_primary_10_1055_s_0040_1709491
crossref_primary_10_1016_j_hpb_2018_06_1809
crossref_primary_10_1111_j_1478_3231_2011_02482_x
crossref_primary_10_1053_j_gastro_2009_04_052
crossref_primary_10_1016_j_jhep_2012_11_021
crossref_primary_10_1111_hepr_12094
crossref_primary_10_3917_heg_041_0002
crossref_primary_10_1055_a_1880_2388
crossref_primary_10_1586_17474124_2015_1049155
crossref_primary_10_14218_JCTH_2017_00009
crossref_primary_10_1002_hep_23312
crossref_primary_10_17116_terarkh201789259_65
crossref_primary_10_1038_s41374_019_0315_9
crossref_primary_10_1371_journal_pone_0277380
crossref_primary_10_1016_j_cgh_2007_06_005
crossref_primary_10_1016_j_cgh_2008_12_015
crossref_primary_10_3748_wjg_v27_i7_609
crossref_primary_10_1002_jmri_24321
crossref_primary_10_1007_s00464_020_07490_y
crossref_primary_10_1007_s00261_014_0137_6
crossref_primary_10_1007_s11605_008_0704_7
crossref_primary_10_1371_journal_pone_0111551
crossref_primary_10_1007_s10620_011_1602_5
crossref_primary_10_1016_j_ejrad_2009_12_033
crossref_primary_10_1088_1361_6560_acb635
crossref_primary_10_3348_kjr_2011_12_4_403
crossref_primary_10_1016_j_gcb_2009_05_011
crossref_primary_10_1016_j_cld_2009_07_008
crossref_primary_10_1016_j_mpdhp_2008_09_005
crossref_primary_10_1055_a_2334_8525
crossref_primary_10_4254_wjh_v2_i7_275
crossref_primary_10_1007_s00261_021_02965_5
crossref_primary_10_1016_j_gcb_2009_05_009
crossref_primary_10_18525_cu_2024_9_1_1
crossref_primary_10_1016_j_jhep_2013_10_017
crossref_primary_10_1016_j_mri_2008_08_008
crossref_primary_10_1111_j_1365_2036_2010_04480_x
crossref_primary_10_1371_journal_pone_0115922
crossref_primary_10_3390_curroncol29070356
crossref_primary_10_1002_hep_21711
crossref_primary_10_1111_hepr_13688
crossref_primary_10_2478_enr_2023_0013
crossref_primary_10_1097_MEG_0b013e32833f14a1
crossref_primary_10_3389_fphar_2016_00159
crossref_primary_10_3350_cmh_2021_0178
crossref_primary_10_1016_j_anndiagpath_2010_08_001
crossref_primary_10_1007_s11695_018_03638_x
crossref_primary_10_4254_wjh_v9_i11_533
crossref_primary_10_1016_j_dld_2017_08_030
crossref_primary_10_1002_hep_31750
crossref_primary_10_1002_jmri_25083
crossref_primary_10_1111_jgh_16673
crossref_primary_10_3390_healthcare10020374
crossref_primary_10_3390_jcm12155072
crossref_primary_10_1016_j_ultrasmedbio_2011_12_023
crossref_primary_10_1016_j_jhep_2017_05_005
crossref_primary_10_21467_ajgr_9_1_46_58
crossref_primary_10_1111_ijpo_12947
crossref_primary_10_1016_j_ajg_2014_01_009
crossref_primary_10_1258_ar_2011_100360
crossref_primary_10_1002_hep_22137
crossref_primary_10_1016_j_gcb_2010_06_004
crossref_primary_10_1002_jmri_23928
crossref_primary_10_1111_j_1477_2574_2011_00380_x
crossref_primary_10_1053_j_sempedsurg_2013_10_016
crossref_primary_10_1111_j_1600_6143_2007_02135_x
crossref_primary_10_1007_s40121_022_00738_1
crossref_primary_10_1016_j_knosys_2014_11_021
crossref_primary_10_1194_jlr_R800089_JLR200
crossref_primary_10_2214_AJR_18_20012
crossref_primary_10_1007_s00330_012_2468_4
crossref_primary_10_1016_j_cld_2009_07_011
crossref_primary_10_1007_s10620_007_9992_0
crossref_primary_10_4093_jkd_2014_15_2_82
crossref_primary_10_1111_j_1651_2227_2007_00423_x
crossref_primary_10_1016_j_cgh_2023_11_044
crossref_primary_10_1097_MCO_0b013e32832eb587
crossref_primary_10_1016_j_acra_2022_12_025
crossref_primary_10_1111_eci_13446
crossref_primary_10_1053_j_gastro_2022_06_073
crossref_primary_10_1016_j_clnesp_2019_10_008
crossref_primary_10_6061_clinics_2019_e1070
crossref_primary_10_1371_journal_pone_0217093
crossref_primary_10_3748_wjg_v20_i36_12956
crossref_primary_10_3917_heg_011_0002
crossref_primary_10_1186_s12876_021_01675_y
Cites_doi 10.1111/j.1572-0241.1999.01377.x
10.1002/hep.20012
10.1053/j.gastro.2005.03.084
10.2307/2529310
10.1056/NEJMra011775
10.1016/j.hepres.2005.09.006
10.1002/hep.20092
10.1016/j.jhep.2004.09.012
10.1016/S0270-9139(03)81112-6
10.1002/hep.20818
10.1111/j.1572-0241.2002.06038.x
10.1053/jhep.2003.50193
10.1056/NEJM200102153440706
10.1055/s-2004-823098
10.1002/hep.20701
10.1002/hep.510280206
10.1016/S1542-3565(04)00457-4
10.1016/0895-4356(93)90018-V
10.1016/S0016-5085(99)70506-8
ContentType Journal Article
Copyright Copyright © 2006 American Association for the Study of Liver Diseases
2006 INIST-CNRS
Copyright_xml – notice: Copyright © 2006 American Association for the Study of Liver Diseases
– notice: 2006 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1002/hep.21346
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-3350
EndPage 880
ExternalDocumentID 10_1002_hep_21346
17006934
18178906
HEP21346
Genre article
Comparative Study
Evaluation Studies
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: American Association for the Study of Liver Diseases
– fundername: National Institute of Diabetes & Digestive & Kidney Diseases
  funderid: DK61989; DK26743
– fundername: National Institutes of Health
– fundername: American Liver Foundation
– fundername: Liver Scholar Award
– fundername: Schering Advanced Hepatology Fellowship Award
– fundername: NIDDK NIH HHS
  grantid: DK61989
– fundername: NIDDK NIH HHS
  grantid: DK26743
GroupedDBID ---
--K
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
186
1B1
1CY
1L6
1OB
1OC
1ZS
1~5
24P
31~
33P
3O-
3SF
3WU
4.4
4G.
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AALRI
AAONW
AAQFI
AAQQT
AAQXK
AASGY
AAXRX
AAXUO
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABLJU
ABMAC
ABOCM
ABPVW
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADOZA
ADXAS
ADZMN
ADZOD
AECAP
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFFNX
AFGKR
AFPWT
AFUWQ
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJAOE
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
F00
F01
F04
F5P
FD8
FDB
FEDTE
FGOYB
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IHE
IX1
J0M
J5H
JPC
KBYEO
KQQ
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
M65
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
NNB
NQ-
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
R2-
RGB
RIG
RIWAO
RJQFR
ROL
RPZ
RWI
RX1
RYL
SEW
SSZ
SUPJJ
TEORI
UB1
V2E
V9Y
W2D
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
X7M
XG1
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
08R
AAPBV
AAUGY
AAVGM
ABHUG
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
BFHJK
IQODW
MEWTI
SAMSI
WXSBR
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ACLDA
CITATION
7X8
ID FETCH-LOGICAL-c3536-b007c1d108bc4792bb1d5c00b7ebe5c18cea79bc8f7a7e58c8cc59cbec4e25dd3
IEDL.DBID 33P
ISSN 0270-9139
IngestDate Fri Oct 25 00:12:35 EDT 2024
Fri Nov 22 02:10:20 EST 2024
Sat Sep 28 07:53:55 EDT 2024
Sun Oct 29 17:07:35 EDT 2023
Sat Aug 24 01:13:20 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Human
Obesity
Biopsy
Non alcoholic steatohepatitis
Nutrition disorder
Gastroenterology
Pair correlation
Digestive diseases
Hepatic disease
Nutritional status
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3536-b007c1d108bc4792bb1d5c00b7ebe5c18cea79bc8f7a7e58c8cc59cbec4e25dd3
Notes fax: 415‐476‐0659
Potential conflict of interest: Nothing to report.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 17006934
PQID 68917825
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_68917825
crossref_primary_10_1002_hep_21346
pubmed_primary_17006934
pascalfrancis_primary_18178906
wiley_primary_10_1002_hep_21346_HEP21346
PublicationCentury 2000
PublicationDate October 2006
PublicationDateYYYYMMDD 2006-10-01
PublicationDate_xml – month: 10
  year: 2006
  text: October 2006
PublicationDecade 2000
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: Hoboken, NJ
– name: United States
PublicationTitle Hepatology (Baltimore, Md.)
PublicationTitleAlternate Hepatology
PublicationYear 2006
Publisher Wiley Subscription Services, Inc., A Wiley Company
Wiley
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
– name: Wiley
References 2001; 344
1993; 46
1998; 28
2002; 97
2004; 39
2005; 128
2004; 24
2005; 41
2002; 346
2003; 37
2005; 42
2003; 38
1977; 33
2004; 2
1999; 94
1999; 116
2005; 33
1998; 11
Ratziu (R10-14-20241029) 2005; 128
Promrat (R5-14-20241029) 2004; 39
Bravo (R7-14-20241029) 2001; 344
Younossi (R20-14-20241029) 1998; 11
Brunt (R18-14-20241029) 2004; 24
Byrt (R19-14-20241029) 1993; 46
Angulo (R1-14-20241029) 2002; 346
Matteoni (R15-14-20241029) 1999; 116
Neuschwander‐Tetri (R2-14-20241029) 2003; 37
Brunt (R3-14-20241029) 2005; 33
Kleiner (R12-14-20241029) 2005; 41
Brunt (R14-14-20241029) 1999; 94
Crawford (R13-14-20241029) 1998; 28
Neuschwander‐Tetri (R4-14-20241029) 2003; 38
Lindor (R8-14-20241029) 2004; 39
Kunde (R17-14-20241029) 2005; 42
Adams (R9-14-20241029) 2005; 42
Sanyal (R6-14-20241029) 2004; 2
Landis (R16-14-20241029) 1977; 33
Mendez (R11-14-20241029) 2003; 38
Regev (R21-14-20241029) 2002; 97
References_xml – volume: 37
  start-page: 1202
  year: 2003
  end-page: 1219
  article-title: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference
  publication-title: HEPATOLOGY
– volume: 39
  start-page: 770
  year: 2004
  end-page: 778
  article-title: Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial
  publication-title: HEPATOLOGY
– volume: 94
  start-page: 2467
  year: 1999
  end-page: 2474
  article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
  publication-title: Am J Gastroenterol
– volume: 24
  start-page: 3
  year: 2004
  end-page: 20
  article-title: Nonalcoholic steatohepatitis
  publication-title: Semin Liver Dis
– volume: 2
  start-page: 1107
  year: 2004
  end-page: 1115
  article-title: A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
  publication-title: Clin Gastroenterol Hepatol
– volume: 128
  start-page: 1898
  year: 2005
  end-page: 1906
  article-title: Sampling variability of liver biopsy in nonalcoholic fatty liver disease
  publication-title: Gastroenterology
– volume: 28
  start-page: 323
  year: 1998
  end-page: 331
  article-title: The normal adult human liver biopsy: a quantitative reference standard
  publication-title: HEPATOLOGY
– volume: 11
  start-page: 560
  year: 1998
  end-page: 565
  article-title: Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations
  publication-title: Mod Pathol
– volume: 346
  start-page: 1221
  year: 2002
  end-page: 1231
  article-title: Nonalcoholic fatty liver disease
  publication-title: N Engl J Med
– volume: 38
  start-page: 1008
  year: 2003
  end-page: 1017
  article-title: Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐gamma ligand rosiglitazone
  publication-title: HEPATOLOGY
– volume: 46
  start-page: 423
  year: 1993
  end-page: 429
  article-title: Bias, prevalence and kappa
  publication-title: J Clin Epidemiol
– volume: 344
  start-page: 495
  year: 2001
  end-page: 500
  article-title: Liver biopsy
  publication-title: N Engl J Med
– volume: 97
  start-page: 2614
  year: 2002
  end-page: 2618
  article-title: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
  publication-title: Am J Gastroenterol
– volume: 33
  start-page: 68
  year: 2005
  end-page: 71
  article-title: Pathology of nonalcoholic steatohepatitis
  publication-title: Hepatol Res
– volume: 116
  start-page: 1413
  year: 1999
  end-page: 1419
  article-title: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity
  publication-title: Gastroenterology
– volume: 33
  start-page: 159
  year: 1977
  end-page: 174
  article-title: The measurement of observer agreement for categorical data
  publication-title: Biometrics
– volume: 41
  start-page: 1313
  year: 2005
  end-page: 1321
  article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease
  publication-title: HEPATOLOGY
– volume: 39
  start-page: 188
  year: 2004
  end-page: 196
  article-title: A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
  publication-title: HEPATOLOGY
– volume: 42
  start-page: 650
  year: 2005
  end-page: 656
  article-title: Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women
  publication-title: HEPATOLOGY
– volume: 38
  start-page: 673A
  issue: Suppl
  year: 2003
  article-title: Sampling error and reliability of liver biopsy in patients with non‐alcoholic fatty liver disease (NAFLD)
  publication-title: HEPATOLOGY
– volume: 42
  start-page: 132
  year: 2005
  end-page: 138
  article-title: The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
  publication-title: J Hepatol
– volume: 94
  start-page: 2467
  year: 1999
  ident: R14-14-20241029
  article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.1999.01377.x
  contributor:
    fullname: Brunt
– volume: 39
  start-page: 188
  year: 2004
  ident: R5-14-20241029
  article-title: A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
  publication-title: HEPATOLOGY
  doi: 10.1002/hep.20012
  contributor:
    fullname: Promrat
– volume: 128
  start-page: 1898
  year: 2005
  ident: R10-14-20241029
  article-title: Sampling variability of liver biopsy in nonalcoholic fatty liver disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.03.084
  contributor:
    fullname: Ratziu
– volume: 33
  start-page: 159
  year: 1977
  ident: R16-14-20241029
  article-title: The measurement of observer agreement for categorical data
  publication-title: Biometrics
  doi: 10.2307/2529310
  contributor:
    fullname: Landis
– volume: 346
  start-page: 1221
  year: 2002
  ident: R1-14-20241029
  article-title: Nonalcoholic fatty liver disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra011775
  contributor:
    fullname: Angulo
– volume: 33
  start-page: 68
  year: 2005
  ident: R3-14-20241029
  article-title: Pathology of nonalcoholic steatohepatitis
  publication-title: Hepatol Res
  doi: 10.1016/j.hepres.2005.09.006
  contributor:
    fullname: Brunt
– volume: 39
  start-page: 770
  year: 2004
  ident: R8-14-20241029
  article-title: Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial
  publication-title: HEPATOLOGY
  doi: 10.1002/hep.20092
  contributor:
    fullname: Lindor
– volume: 42
  start-page: 132
  year: 2005
  ident: R9-14-20241029
  article-title: The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2004.09.012
  contributor:
    fullname: Adams
– volume: 38
  start-page: 673A
  year: 2003
  ident: R11-14-20241029
  article-title: Sampling error and reliability of liver biopsy in patients with non‐alcoholic fatty liver disease (NAFLD)
  publication-title: HEPATOLOGY
  doi: 10.1016/S0270-9139(03)81112-6
  contributor:
    fullname: Mendez
– volume: 42
  start-page: 650
  year: 2005
  ident: R17-14-20241029
  article-title: Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women
  publication-title: HEPATOLOGY
  doi: 10.1002/hep.20818
  contributor:
    fullname: Kunde
– volume: 97
  start-page: 2614
  year: 2002
  ident: R21-14-20241029
  article-title: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2002.06038.x
  contributor:
    fullname: Regev
– volume: 37
  start-page: 1202
  year: 2003
  ident: R2-14-20241029
  article-title: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference
  publication-title: HEPATOLOGY
  doi: 10.1053/jhep.2003.50193
  contributor:
    fullname: Neuschwander‐Tetri
– volume: 344
  start-page: 495
  year: 2001
  ident: R7-14-20241029
  article-title: Liver biopsy
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200102153440706
  contributor:
    fullname: Bravo
– volume: 38
  start-page: 1008
  year: 2003
  ident: R4-14-20241029
  article-title: Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐gamma ligand rosiglitazone
  publication-title: HEPATOLOGY
  contributor:
    fullname: Neuschwander‐Tetri
– volume: 24
  start-page: 3
  year: 2004
  ident: R18-14-20241029
  article-title: Nonalcoholic steatohepatitis
  publication-title: Semin Liver Dis
  doi: 10.1055/s-2004-823098
  contributor:
    fullname: Brunt
– volume: 41
  start-page: 1313
  year: 2005
  ident: R12-14-20241029
  article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease
  publication-title: HEPATOLOGY
  doi: 10.1002/hep.20701
  contributor:
    fullname: Kleiner
– volume: 28
  start-page: 323
  year: 1998
  ident: R13-14-20241029
  article-title: The normal adult human liver biopsy: a quantitative reference standard
  publication-title: HEPATOLOGY
  doi: 10.1002/hep.510280206
  contributor:
    fullname: Crawford
– volume: 2
  start-page: 1107
  year: 2004
  ident: R6-14-20241029
  article-title: A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/S1542-3565(04)00457-4
  contributor:
    fullname: Sanyal
– volume: 11
  start-page: 560
  year: 1998
  ident: R20-14-20241029
  article-title: Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations
  publication-title: Mod Pathol
  contributor:
    fullname: Younossi
– volume: 46
  start-page: 423
  year: 1993
  ident: R19-14-20241029
  article-title: Bias, prevalence and kappa
  publication-title: J Clin Epidemiol
  doi: 10.1016/0895-4356(93)90018-V
  contributor:
    fullname: Byrt
– volume: 116
  start-page: 1413
  year: 1999
  ident: R15-14-20241029
  article-title: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(99)70506-8
  contributor:
    fullname: Matteoni
SSID ssj0009428
Score 2.4119086
Snippet In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 874
SubjectTerms Adult
Aged
Biological and medical sciences
Biopsy - methods
Fatty Liver - classification
Fatty Liver - etiology
Fatty Liver - pathology
Female
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Inflammation
Liver - pathology
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Metabolic diseases
Middle Aged
Obesity
Obesity, Morbid - complications
Observer Variation
Other diseases. Semiology
Prospective Studies
Title Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.21346
https://www.ncbi.nlm.nih.gov/pubmed/17006934
https://search.proquest.com/docview/68917825
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA66BxHE-6VeZhAffKlrek3xSebGXpSBCr6VJM2wMNeyrg_7956TdhsDBcG3FpKmnEtyLjnfIeSWyRCs1kDYeLjaWLNsxxL0UQtPMhVKtCkwdPEavXzwpx7C5DwsamFqfIhlwA01w-zXqOBClp0VaOinLu4RjgzhtsFLMOUb3nAFuOubvqrgdTmYXY4XqEKO21nOXDuLdgpRAllGdT-LnwzOdfvVHED9vX_9-j7ZbexO-lgLygHZ0JNDsvXcZNaPSN7FNh31xTiaj2ghYC9M6RivbVCZ5UUJLjXNJvQrn8osHc9pLnWpaYPLWlIM6NKyMpWbMHGCFr7pvpspOhKz2bz5VpMROibv_d5bd2A3zRhs5QVeiI16IsVS5nCp_Ch2pWRpoBxHRiAGgWJcaRHFUvFRJCIdcMWVCmIFIuJrN0hT74S0YGl9RihT3I9d5TDheL5IwxiMBnjFmGoQSkdZ5GbBlqSoMTeSGl3ZTYB0iSGdRdprDFuN5AyLe2HA9YKDCagM5kHEROdVmYQcfFQQUIuc1oxdzY0QudnzLXJn-Pf78smgNzQP538fekG2TQDHXAW8JK3ZtNJXZLNMq7aR3W_P-PFD
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50BRXE92N9BvHgpW7TZwpeRFdWfCCo4K0kaRYXdFvs7mH_vTNp12VBQfDWQtKUzEzyZSbzDcAJVxGi1lA6tLk6lLPsJArt0UhfcR0pwhTkuniKH17FVZtocs7HuTAVP8S3w40sw67XZODkkG5NWEPfTHFGfGTRLMwFESoiJXD4jxPK3cBWVsVzl0vx5WTMK-R6re-uU7vRUiFLnJhuVdHiJ8g5jWDtFnS98r-fX4XlGnqyi0pX1mDG9Ndh_r4Orm9AfkmVOqq7cSzvskLicpixd7q5wVQvL0o8VbNen33kn6qXvY9YrkxpWE3NWjLy6bJyaJM3sWOfQL4twNvTrCsHg1H9rTootAkv1-3ny45T12NwtB_6EdXqiTXPuCuUDuLEU4pnoXZdFaMmhJoLbWScKC26sYxNKLTQOkw0aklgvDDL_C1o4NBmBxjXIkg87XLp-oHMogRxA76SWzWMlKubcDyWS1pUtBtpRbDspTh1qZ26JhxOSWzSUnDK78UGR2MRpmg1FAqRfZMPyzQSeExFHW3CdiXZSd-YyJv9oAmnVoC_D5922o_2YffvTY9gofN8f5fe3Tzc7sGi9efYm4H70Bh8Ds0BzJbZ8NAq8hcF5fVr
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dSxtBEB-qQhBK1aptWqtL8cGXM7f3uUefRBMsthJQwbdjvw4DMXfkkgf_-87sXRICCkLf7mD39tiZ2f3tzM5vAE65ShC1xtKjzdWjnGUvU2iPVoaK60QRpiDXxV16-yiu-kST82uRC9PwQywdbmQZbr0mA69M0VuRhj7Z6pzoyJIN2IoQhhNxfhgOV4y7kSusiscun8LL2YJWyA96y65rm9HHStY4L0VT0OI1xLkOYN0ONNj5r3_fhU8t8GQXjabswQc7-Qydv21ofR_KS6rT0dyMY2XBKomLoWFjurfB1KisajxTs9GEPZdTNTLjF1YqW1vWErPWjDy6rJ671E3sOCGI78rvjjQr5Gz20n6rDQkdwMOgf3957bXVGDwdxmFClXpSzQ33hdJRmgVKcRNr31cp6kGsudBWppnSokhlamOhhdZxplFHIhvExoSHsIlD26_AuBZRFmifSz-MpEkyRA34Sk7VOFG-7sLPhVjyqiHdyBt65SDHqcvd1HXheE1gq5aCU3YvNjhZSDBHm6FAiJzYcl7nicBDKmpoF740gl31TYm6OYy6cObk9_bw-XV_6B6-vb_pCXSGV4P8z-_bm--w7Zw57lrgEWzOpnP7AzZqMz92avwPGpr0EQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlation+of+paired+liver+biopsies+in+morbidly+obese+patients+with+suspected+nonalcoholic+fatty+liver+disease&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Merriman%2C+Raphael+B.&rft.au=Ferrell%2C+Linda+D.&rft.au=Patti%2C+Marco+G.&rft.au=Weston%2C+Shiobhan+R.&rft.date=2006-10-01&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0270-9139&rft.eissn=1527-3350&rft.volume=44&rft.issue=4&rft.spage=874&rft.epage=880&rft_id=info:doi/10.1002%2Fhep.21346&rft.externalDBID=10.1002%252Fhep.21346&rft.externalDocID=HEP21346
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon